La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Art Vivant Bilan de santé

Santé financière contrôle des critères 3/6

Art Vivant possède un total de capitaux propres de ¥16.0B et une dette totale de ¥11.2B, ce qui porte son ratio d'endettement à 70%. Son actif total et son passif total sont ¥34.5B et de ¥18.4B. L'EBIT de Art Vivant est ¥2.0B ce qui fait que son ratio de couverture des intérêts -34. Elle dispose de liquidités et de placements à court terme de ¥4.4B.

Informations clés

70.0%

Ratio d'endettement

JP¥11.23b

Dette

Ratio de couverture des intérêts	-34x
Argent liquide	JP¥4.41b
Fonds propres	JP¥16.03b
Total du passif	JP¥18.43b
Total des actifs	JP¥34.46b

Mises à jour récentes de la santé financière

Art Vivant (TYO:7523) Seems To Use Debt Quite Sensibly

Feb 08

Recent updates

Additional Considerations Required While Assessing Art Vivant's (TSE:7523) Strong Earnings

May 22

How Much Did Art Vivant's(TYO:7523) Shareholders Earn From Share Price Movements Over The Last Three Years?

Dec 15

Are Art Vivant's (TYO:7523) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 27

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 7523 ( ¥29.2B ) dépassent ses passifs à court terme ( ¥16.4B ).

Passif à long terme: Les actifs à court terme de 7523 ( ¥29.2B ) dépassent ses passifs à long terme ( ¥2.0B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de 7523 ( 42.5% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de 7523 est passé de 48.8% à 70% au cours des 5 dernières années.

Couverture de la dette: Le flux de trésorerie opérationnel de 7523 est négatif, par conséquent la dette n'est pas bien couverte.

Couverture des intérêts: 7523 gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.

Art Vivant Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Art Vivant (TYO:7523) Seems To Use Debt Quite Sensibly

Recent updates

First quarter 2025 earnings released: EPS: JP¥46.50 (vs JP¥70.67 in 1Q 2024)

Investor sentiment deteriorates as stock falls 17%

Full year 2024 earnings released: EPS: JP¥164 (vs JP¥124 in FY 2023)

Additional Considerations Required While Assessing Art Vivant's (TSE:7523) Strong Earnings

Full year 2024 earnings released: EPS: JP¥164 (vs JP¥124 in FY 2023)

Art Vivant Co., Ltd., Annual General Meeting, Jun 24, 2024

Upcoming dividend of JP¥30.00 per share

Art Vivant Co., Ltd. (TSE:7523) announces an Equity Buyback for 550,000 shares, representing 5.14% for ¥652.3 million.

Art Vivant Co., Ltd. to Report Fiscal Year 2024 Results on May 15, 2024

Third quarter 2024 earnings released: EPS: JP¥37.39 (vs JP¥57.70 in 3Q 2023)

Art Vivant Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024

Second quarter 2024 earnings released: EPS: JP¥36.22 (vs JP¥41.68 in 2Q 2023)

Investor sentiment deteriorates as stock falls 16%

Art Vivant Co., Ltd. (TSE:7523) announces an Equity Buyback for 300,000 shares, representing 2.76% for ¥369 million.

Upcoming dividend of JP¥30.00 per share at 2.5% yield

Art Vivant Co., Ltd. to Report Q2, 2024 Results on Nov 10, 2023

First quarter 2024 earnings released: EPS: JP¥70.66 (vs JP¥29.66 in 1Q 2023)

Art Vivant Co., Ltd. (TSE:7523) announces an Equity Buyback for 150,000 shares, representing 1.37% for ¥150 million.

Art Vivant Co., Ltd. to Report Q1, 2024 Results on Aug 10, 2023

Full year 2023 earnings released: EPS: JP¥124 (vs JP¥107 in FY 2022)

Investor sentiment improves as stock rises 17%

Upcoming dividend of JP¥15.00 per share at 4.8% yield

Third quarter 2023 earnings released: EPS: JP¥57.69 (vs JP¥35.11 in 3Q 2022)

Art Vivant Co., Ltd. to Report Q3, 2023 Results on Feb 10, 2023

Art Vivant Co., Ltd. (TSE:7523) announces an Equity Buyback for 300,000 shares, representing 2.72% for ¥200 million.

Second quarter 2023 earnings released: EPS: JP¥41.67 (vs JP¥40.04 in 2Q 2022)

No independent directors

Second quarter 2023 earnings released: EPS: JP¥41.67 (vs JP¥40.04 in 2Q 2022)

Upcoming dividend of JP¥15.00 per share

Art Vivant Co., Ltd. to Report Q2, 2023 Results on Nov 11, 2022

First quarter 2023 earnings released: EPS: JP¥29.66 (vs JP¥38.41 in 1Q 2022)

Art Vivant Co., Ltd. to Report Q1, 2023 Results on Aug 10, 2022

Art Vivant Co., Ltd., Annual General Meeting, Jun 24, 2022

No independent directors

Art Vivant Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥15.00 per share

Second quarter 2022 earnings released: EPS JP¥41.52 (vs JP¥20.12 in 2Q 2021)

Upcoming dividend of JP¥15.00 per share

First quarter 2022 earnings released: EPS JP¥41.32 (vs JP¥1.90 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥55.32 (vs JP¥99.79 in FY 2020)

Art Vivant's (TYO:7523) Returns On Capital Are Heading Higher

Upcoming dividend of JP¥15.00 per share

Should Art Vivant (TYO:7523) Be Disappointed With Their 63% Profit?

Art Vivant Co., Ltd. to Report Fiscal Year 2021 Results on May 14, 2021

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS JP¥42.58 (vs JP¥33.29 in 3Q 2020)

New 90-day high: JP¥585

Art Vivant (TYO:7523) Seems To Use Debt Quite Sensibly

New 90-day high: JP¥550

Is Art Vivant (TYO:7523) A Future Multi-bagger?

Would Art Vivant Co., Ltd. (TYO:7523) Be Valuable To Income Investors?

How Much Did Art Vivant's(TYO:7523) Shareholders Earn From Share Price Movements Over The Last Three Years?

Art Vivant Co., Ltd. to Report Q3, 2021 Results on Feb 12, 2021

Are Art Vivant's (TYO:7523) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Second quarter 2021 earnings released: EPS JP¥20.12

Upcoming Dividend of JP¥15.00 Per Share

New 90-day high - JP¥529

Art Vivant Co., Ltd. to Report Q2, 2021 Results on Nov 12, 2020

New 90-day high - JP¥513

First quarter earnings released

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines